by Eric Christianson | Aug 28, 2022 | Uncategorized
The P2Y12 inhibitors are frequently used in the management of ACS and other coronary syndromes. They have some clinical quirks you need to be aware of and I will highlight some of my most important (not ALL inclusive) warnings for the P2Y12 inhibitors. Clopidogrel...
by Eric Christianson | Aug 24, 2022 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
I frequently work with patients and caregivers who are managing patients at the end of life and in hospice-type situations. Knowing and understanding differences between common opioids is critical to my work as a clinical pharmacist. In this article, I’ll...
by Eric Christianson | Aug 21, 2022 | Respiratory Case Studies
KE is a 66-year-old male with a history of cigarette smoking (still currently smoking), COPD, atrial fibrillation, hypertension, osteoarthritis, and GERD. In this COPD case review, he reports that he is having a more difficult time breathing, in particular, he notes...
by Eric Christianson | Aug 17, 2022 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Bipolar disorder medications contain a treasure trove of clinical pearls that a clinical pharmacist must know. Many of the frequently used medications have numerous clinical quirks that may encourage you to use the medication or discourage you from use. Let’s...
by Eric Christianson | Aug 14, 2022 | Polypharmacy Cases And The Prescribing Cascade
In most clinical situations, I’m a stickler for trying to prevent the prescribing cascade. I lay out hundreds of polypharmacy case examples including the prescribing cascade in my highly rated book Perils of Polypharmacy. The prescribing cascade is simply...
